$4.21
0.28[7.12%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$4.21
0[0.00%]
| Open4.030 | Close4.210 |
| Vol / Avg.369.374K / 138.545K | Mkt Cap104.222M |
| Day Range3.830 - 4.550 | 52 Wk Range2.190 - 5.790 |
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%
Abeona Therapeutics Stock (NASDAQ:ABEO), Key Statistics
Abeona Therapeutics Stock (NASDAQ: ABEO) analysis, key statistics.
Valuation Measures
Enterprise Value
74.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
15.08
Price / Book (mrq)
10.41
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-47.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.38
Tangible Book value per share
0.38
Total Liabilities (Quarterly)
44.2M
Total Assets
53.5M
Total Liabilities
44.2M
Profitability
Net income Growth
- -
Gross Margin
55%
Net Margin
-475.83%
EBIT Margin
-472.89%
EBITDA Margin
-448.94%
Operating Margin
-331.97%